{
  "retracted": false,
  "timestamp": 1457481600000,
  "updates": [
    {
      "timestamp": 1585046278441,
      "identifier": {
        "doi": "10.1007/s10549-016-3703-5"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10549-012-2080-y"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients"
}
